Sign in

CIK 0001159036 · Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880488686
Phone
(858) 794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,884,955
in 5 filings, $19.9M under 10b5-1 plans

Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-13 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −600 $70.81 $42K 767,780
2026-05-13 Torley Helen PRESIDENT AND CEO Option exercise · Option to Purchase Common Stock 10b5-1 −10,000 $12.07 $121K 51,923
2026-05-12 Torley Helen PRESIDENT AND CEO Option exercise 10b5-1 +20,000 $12.07 $241K 787,780
2026-05-12 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −100 $67.85 $7K 787,680
2026-05-12 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −1,398 $70.29 $98K 786,282
2026-05-12 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −9,802 $71.37 $700K 776,480
2026-05-12 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −5,900 $72.15 $426K 770,580
2026-05-12 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −2,800 $73.12 $205K 767,780
2026-05-12 Torley Helen PRESIDENT AND CEO Option exercise · Option to Purchase Common Stock 10b5-1 −20,000 $12.07 $241K 61,923
2026-05-11 Torley Helen PRESIDENT AND CEO Option exercise 10b5-1 +20,000 $12.07 $241K 787,780
2026-05-11 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −9,725 $64.63 $629K 778,055
2026-05-11 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −3,575 $65.46 $234K 774,480
2026-05-11 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −6,700 $66.33 $444K 767,780
2026-05-11 Torley Helen PRESIDENT AND CEO Option exercise · Option to Purchase Common Stock 10b5-1 −20,000 $12.07 $241K 81,923
2026-05-05 Connaughton Bernadette Director Grant or award +3,796 42,294
2026-05-05 Posard Matthew L. Director Grant or award +3,796 77,835
2026-05-05 Posard Matthew L. Director Grant or award · Option to Purchase Common Stock +6,040 6,040
2026-05-05 Krishnan Mahesh Director Grant or award +3,796 14,462
2026-05-05 Krishnan Mahesh Director Grant or award · Option to Purchase Common Stock +6,040 6,040
2026-05-05 Lang James Paul Director Grant or award +3,796 4,685

Page 6 of 26 · 513 trades